Screener
Ligand Pharmaceuticals LGND Interest Expense
Interest Expense at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
| Line item | Three months ended / June 30, 2026 | Three months ended / June 30, 2025 | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|---|---|
| Gain (loss) from short-term investments | 11,754 | 939 | 15,623 | (11,428) |
| Gain (loss) from change in fair value of equity-method investments and other investments | 35,727 | — | (13,502) | — |
| Interest income | 7,298 | 1,621 | 13,953 | 3,392 |
| Interest expense | (1,748) | (1,153) | (3,495) | (2,020) |
| Other non-operating expense, net | 2,682 | 1,372 | 1,507 | (1,129) |
| Total non-operating income (expenses), net | 55,713 | 2,779 | 14,086 | (11,185) |
| Income (loss) before income taxes | 64,304 | 11,223 | 40,045 | (38,957) |
| Income tax (expense) benefit | (15,796) | (6,376) | (4,882) | 1,353 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ligand Pharmaceuticals's interest expense?
- Ligand Pharmaceuticals (LGND) reported interest expense of $1.75M in Q2 2026.
- How has Ligand Pharmaceuticals's interest expense changed year-over-year?
- Ligand Pharmaceuticals's interest expense increased by 51.6% year-over-year, from $1.15M to $1.75M.
- What is the long-term trend for Ligand Pharmaceuticals's interest expense?
- Over 4 years (2021 to 2025), Ligand Pharmaceuticals's interest expense has grown at a -30.0% compound annual growth rate (CAGR), from $19.62M to $4.72M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Ligand Pharmaceuticals's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude